37.74 USD
-0.42 (-1.1%)
At close: Feb 3, 2026
37.74 USD
0 (0%)
After Hours: 2/3/2026, 8:00:02 PM
We assign a fundamental rating of 6 out of 10 to VCYT. VCYT was compared to 524 industry peers in the Biotechnology industry. VCYT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. VCYT is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make VCYT a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
- In the past year VCYT was profitable.
- VCYT had a positive operating cash flow in the past year.
- VCYT had negative earnings in 4 of the past 5 years.
- In multiple years VCYT reported negative operating cash flow during the last 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 2.22%, VCYT belongs to the top of the industry, outperforming 89.31% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 2.41%, VCYT belongs to the top of the industry, outperforming 90.27% of the companies in the same industry.
- The Return On Invested Capital of VCYT (2.93%) is better than 90.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.22% | ||
| ROE | 2.41% | ||
| ROIC | 2.93% |
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Profit Margin value of 6.12%, VCYT belongs to the best of the industry, outperforming 90.08% of the companies in the same industry.
- Looking at the Operating Margin, with a value of 9.70%, VCYT belongs to the top of the industry, outperforming 91.60% of the companies in the same industry.
- VCYT has a Gross Margin of 68.53%. This is amongst the best in the industry. VCYT outperforms 81.11% of its industry peers.
- In the last couple of years the Gross Margin of VCYT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.7% | ||
| PM (TTM) | 6.12% | ||
| GM | 68.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VCYT is destroying value.
- VCYT has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, VCYT has more shares outstanding
- There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 16.64 indicates that VCYT is not in any danger for bankruptcy at the moment.
- VCYT's Altman-Z score of 16.64 is amongst the best of the industry. VCYT outperforms 87.02% of its industry peers.
- VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 16.64 |
ROIC/WACC0.33
WACC8.93%
2.3 Liquidity
- VCYT has a Current Ratio of 6.23. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
- VCYT has a better Current ratio (6.23) than 63.74% of its industry peers.
- VCYT has a Quick Ratio of 5.94. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
- With a decent Quick ratio value of 5.94, VCYT is doing good in the industry, outperforming 63.17% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.23 | ||
| Quick Ratio | 5.94 |
3. Growth
3.1 Past
- VCYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 353.33%, which is quite impressive.
- Looking at the last year, VCYT shows a quite strong growth in Revenue. The Revenue has grown by 16.41% in the last year.
- VCYT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.93% yearly.
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
3.2 Future
- VCYT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.21% yearly.
- VCYT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.52% yearly.
EPS Next Y79.07%
EPS Next 2Y88.85%
EPS Next 3Y64.96%
EPS Next 5Y51.21%
Revenue Next Year14.79%
Revenue Next 2Y13.07%
Revenue Next 3Y12.72%
Revenue Next 5Y11.52%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 99.32, the valuation of VCYT can be described as expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 89.89% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 28.18, VCYT is valued quite expensively.
- The Price/Forward Earnings ratio is 35.27, which means the current valuation is very expensive for VCYT.
- Based on the Price/Forward Earnings ratio, VCYT is valued cheaply inside the industry as 91.41% of the companies are valued more expensively.
- VCYT is valuated rather expensively when we compare the Price/Forward Earnings ratio to 25.51, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 99.32 | ||
| Fwd PE | 35.27 |
4.2 Price Multiples
- 91.79% of the companies in the same industry are more expensive than VCYT, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, VCYT is valued cheaply inside the industry as 94.08% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.45 | ||
| EV/EBITDA | 36.59 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- VCYT has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as VCYT's earnings are expected to grow with 64.96% in the coming years.
PEG (NY)1.26
PEG (5Y)N/A
EPS Next 2Y88.85%
EPS Next 3Y64.96%
5. Dividend
5.1 Amount
- VCYT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
37.74
-0.42 (-1.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners114.83%
Inst Owner Change-2.01%
Ins Owners0.42%
Ins Owner Change-3.94%
Market Cap2.98B
Revenue(TTM)495.14M
Net Income(TTM)30.31M
Analysts82.11
Price Target49.7 (31.69%)
Short Float %6.58%
Short Ratio6.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.65%
Min EPS beat(2)-110.32%
Max EPS beat(2)79.03%
EPS beat(4)2
Avg EPS beat(4)-1.91%
Min EPS beat(4)-110.32%
Max EPS beat(4)79.03%
EPS beat(8)5
Avg EPS beat(8)108.97%
EPS beat(12)8
Avg EPS beat(12)67.3%
EPS beat(16)12
Avg EPS beat(16)58.01%
Revenue beat(2)2
Avg Revenue beat(2)4.54%
Min Revenue beat(2)3.31%
Max Revenue beat(2)5.76%
Revenue beat(4)3
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)4.03%
Revenue beat(12)11
Avg Revenue beat(12)4.6%
Revenue beat(16)15
Avg Revenue beat(16)5.32%
PT rev (1m)0.75%
PT rev (3m)15.74%
EPS NQ rev (1m)3.75%
EPS NQ rev (3m)12.16%
EPS NY rev (1m)1.28%
EPS NY rev (3m)42.34%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)1.52%
Revenue NY rev (1m)0.26%
Revenue NY rev (3m)1.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 99.32 | ||
| Fwd PE | 35.27 | ||
| P/S | 6.03 | ||
| P/FCF | 30.45 | ||
| P/OCF | 27.69 | ||
| P/B | 2.37 | ||
| P/tB | 7.5 | ||
| EV/EBITDA | 36.59 |
EPS(TTM)0.38
EY1.01%
EPS(NY)1.07
Fwd EY2.84%
FCF(TTM)1.24
FCFY3.28%
OCF(TTM)1.36
OCFY3.61%
SpS6.26
BVpS15.91
TBVpS5.04
PEG (NY)1.26
PEG (5Y)N/A
Graham Number11.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.22% | ||
| ROE | 2.41% | ||
| ROCE | 3.71% | ||
| ROIC | 2.93% | ||
| ROICexc | 4.08% | ||
| ROICexgc | 54.52% | ||
| OM | 9.7% | ||
| PM (TTM) | 6.12% | ||
| GM | 68.53% | ||
| FCFM | 19.79% |
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score8
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 44.07% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 153.6% | ||
| Profit Quality | 323.21% | ||
| Current Ratio | 6.23 | ||
| Quick Ratio | 5.94 | ||
| Altman-Z | 16.64 |
F-Score8
WACC8.93%
ROIC/WACC0.33
Cap/Depr(3y)39.24%
Cap/Depr(5y)36.19%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y79.07%
EPS Next 2Y88.85%
EPS Next 3Y64.96%
EPS Next 5Y51.21%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
Revenue Next Year14.79%
Revenue Next 2Y13.07%
Revenue Next 3Y12.72%
Revenue Next 5Y11.52%
EBIT growth 1Y427.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year320.9%
EBIT Next 3Y74.34%
EBIT Next 5Y48.27%
FCF growth 1Y236.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.39%
OCF growth 3YN/A
OCF growth 5YN/A
VERACYTE INC / VCYT FAQ
What is the fundamental rating for VCYT stock?
ChartMill assigns a fundamental rating of 6 / 10 to VCYT.
What is the valuation status of VERACYTE INC (VCYT) stock?
ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.
How profitable is VERACYTE INC (VCYT) stock?
VERACYTE INC (VCYT) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for VCYT stock?
The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 99.32 and the Price/Book (PB) ratio is 2.37.
What is the financial health of VERACYTE INC (VCYT) stock?
The financial health rating of VERACYTE INC (VCYT) is 8 / 10.